The Back

Published on 16/03/2015 by admin

Filed under Orthopaedics

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1963 times

Chapter 8 The Back

Back pain is one of the most frequent conditions requiring medical treatment. It is also the most expensive ailment for patients between the ages of 30 and 60 years and one of the most difficult to treat. Back pain may be caused by a variety of disorders, including gynecologic, genitourinary, and gastrointestinal diseases, but the most common causes are disorders of the lumbar disc.

History

The evaluation of the patient with back pain should first begin with the obvious questions regarding the common causes of spine disorders (trauma, disc disease, degenerative disorders, etc.). However, because low back discomfort can develop in conjunction with a variety of diseases not considered orthopedic in nature, this initial assessment should also include information developed about general medical disorders that could be causally connected with the spine complaints. This is especially true if the symptoms appear atypical (pain radiating into the groin, testicle, vulva, or inner thigh). If this cannot be done on the initial visit because of limited time, it eventually must be done if the patient’s condition does not improve and the patient returns with the same complaints.

A few simple questions should be sufficient for general system review as follow:

The smoking history is always critical. In addition, certain “red flags” should signal the possibility of a more serious condition underlying the low back complaints (Table 8-1).

Table 8-1 Red Flags

Fever, malaise
History of malignancy
Night pain or pain at rest (suggests spinal malignancy)
Incontinence, perianal sensory loss
Weight loss of unknown origin
Loss of strength, balance
Sudden worsening of pain level
History of substance abuse or issues of secondary gain
Night sweats
Significant morning stiffness

Examination

Valuable information can be gained by simple observation of the patient getting in and out of the chair and then moving around naturally in the examination room. The gait pattern can easily be assessed at this time as well. Then, examination of the back is performed with the patient standing, sitting on the examining table, and then lying in the supine position. The back is first inspected with the patient in the standing position. Any areas of enlargement are noted. The back is palpated for points of tenderness, and any list or excessive kyphosis or lordosis is noted. Next, the chest is measured in full inspiration and expiration. Normal expansion is greater than 5 cm but may be less than 2.5 cm in patients with ankylosing spondylitis. The iliac crests are then palpated to determine whether they are level. If they are not, footboards of varying thicknesses may be placed under the shorter extremity to assess the amount of shoe lift necessary to level the pelvis. (Up to 2 cm of leg length difference seems to be well tolerated with no apparent increase in the rate of low back pain.) The shoulders are also observed for evenness, although the dominant shoulder is frequently lower in the normal population. The spine and sacroiliac joints are palpated and percussed for tenderness. Any varicosities in the lower extremities are also noted.

The range of motion is then slowly tested. With the patient bending forward as far as possible, flexion is measured as the distance between the fingertips and the floor. This calculation represents a combination of lumbar spine mobility and hamstring flexibility. While the patient is flexed forward, the back is viewed from behind to detect any scoliosis and from the side to detect any persistence of the normal lumbar lordosis that might be present secondary to protective muscle guarding. Extension and right and left bending are then measured. Pain on bending toward the affected side frequently signifies disc disease, whereas pain on bending away from the affected side frequently denotes muscle strain. The gait pattern is again observed, and the ability to walk on the heels (L5 root) and balls of the feet (S1 root) is tested (“toe and heel walking”).

With the patient in the sitting position, a complete neurologic examination of the lower extremities is performed. Reflexes, motor strength, and sensation are tested. The thighs and calves are measured to detect any muscular atrophy. Discrepancies of greater than ½ inch in the thigh and ¼ inch in the calf are significant. Straight leg raising in the sitting position is also tested and compared with straight leg raising tests that will be performed in the supine position. The peripheral pulses are palpated and any abnormalities in the vascular status of the extremity noted, especially dependent rubor.

With the patient in the supine position, the hip is placed through a full range of motion and thoroughly tested to rule out primary hip abnormality. The straight-leg–raising tests are then performed, and the leg lengths are measured (Fig. 8-3). Next, with the patient on the side, manual pressure is applied to the iliac crest (pelvic compression test). Reproduction of pain in the sacroiliac joints or symphysis pubis with this maneuver may suggest disorders of these areas. The presence or absence of clonus can be determined at this time, and Babinski testing can be performed (Fig. 8-4).

At this time, if it is indicated, a more complete general examination focusing on a particular system or area can be performed if an underlying medical disorder is suspected as the cause of the back pain.

Lumbar Disc Syndromes

The intervertebral disc is probably the major source of most back pain, and the pattern of disc deterioration in the lumbar spine is similar to what occurs in the cervical spine. The majority (95%) of disc lesions in the lumbar spine occur at the fourth and fifth spaces, with most of the remainder occurring at the third space. With normal aging, biochemical and mechanical changes occur in the nucleus pulposus. Eventually, disc material may begin to protrude or even herniate into the neural canal. This most often occurs in the area of greatest weakness of the anulus fibrosus at the posterolateral aspect of the disc (Fig. 8-7). Herniation is most common in the third and fourth decades and is rare before the age of 15. Chronic disc deterioration (spondylosis) may also develop over time and result in osteophyte formation, disc space narrowing, and degenerative changes in the facet joints and between adjacent vertebral bodies. (NOTE: In addition to mechanical causes, chemical and inflammatory factors may also play some role in the development of back pain. Although the mechanical causes may be the easiest to visually understand, a precise diagnosis as to the etiology of back pain in many patients simply cannot be established with any certainty.)

A rare but serious complication of lumbar disc disease is the cauda equina syndrome. This results from a massive central disc herniation and may produce variable degrees of permanent paralysis in the lower extremities. Bladder and bowel function may also be severely impaired. This condition is a true emergency and usually demands immediate evaluation and surgery.

CLINICAL FEATURES

Disc disease (herniation and/or degeneration) may result in several overlapping clinical syndromes: (1) mild herniation without nerve root compression; (2) herniation with nerve root compression; (3) cauda equina syndrome; (4) chronic degenerative disease with or without leg symptoms; and (5) spinal stenosis.

The onset of symptoms from disc herniation is variable. One specific traumatic episode may produce symptoms, but because of the progressive nature of the disease process in the disc, the symptoms usually develop gradually as the disc slowly changes. (How much herniation is required to produce symptoms is unknown, but “bulging” of the disc commonly reported on magnetic resonance imaging [MRI] studies is probably not sufficient.) The most common complaint is low back pain, which is often deep and aching in nature. This pain, which is sometimes referred to as axial, is usually one sided and may be aggravated by activity and relieved by rest. Coughing, sneezing, or other actions that increase the stress on the disc tend to intensify the pain. The back pain is often localized near the disc and may be referred to the iliac crest or buttock. It is may be the result of stretching of the anulus by the expanding, protruding disc. Radicular pain occurs when the disc protrudes far enough to press on the adjacent nerve root. Nerve root pain is usually quite intense. Often, if the disc herniates completely (extrudes), the low back pain may be relieved because the tension on the anulus is gone, but the leg pain intensifies.

Axial low back pain may occur in combination with radiating pain, or the two pain patterns may occur separately. Radicular pain characteristically spreads over the buttock and passes down the posterior or posterolateral aspect of the thigh and calf and may even spread onto the foot. Both types of pain usually improve with bed rest. If little or no relief of pain occurs with rest, inorganic causes should be considered. Relentless pain that is not relieved or may even be aggravated by recumbency suggests a spinal cord tumor.

Paresthesias in the form of numbness and tingling are common and are usually more marked in the distal portion of the extremity. They may follow a specific dermatome pattern (Fig. 8-8).

Examination often reveals restriction of low back motion. Bending toward the affected side frequently exacerbates the pain. Variable degrees of local tenderness and muscle guarding are present. In an attempt to relieve pressure or tension on the nerve root, the patient may list or bend away from the painful side and stand with the affected hip and knee slightly flexed. A characteristic clinical picture may be present, depending on the level of nerve root involvement (Table 8-2). The sensory examination may reveal diminished sensation along the affected dermatome, although the sensory examination is usually not very helpful. The various tests measuring sciatic nerve root tension are frequently positive if herniation is causing nerve compression (Fig. 8-9).

TREATMENT

The initial treatment is always conservative, and the majority of patients respond well. Treatment is based on the symptoms of the patient and not on any imaging study. Extended periods of inactivity are no longer recommended for most low back disorders, but a short period of bed rest (5 to 10 days) may be very helpful in the treatment of acute disc herniation, mainly if radicular leg pain caused by nerve root compression is present. This is followed by a careful exercise program. While the patient is in bed, the hips and knees are kept moderately flexed. Lying on the abdomen, which increases the lumbar lordosis, is avoided. Hip flexion and pelvic tilt exercises are begun within the limits of pain (Fig. 8-11). Nonsteroidal anti-inflammatory drugs (NSAIDs), analgesics, and moist heat are used as necessary. Narcotics may even be required in cases of nerve root compression and intense leg pain. If improvement occurs, which it does in the majority of cases, gradual resumption of activity is allowed, and the exercise program is expanded. Physical therapy is often useful, mainly for the exercise program. Modalities such as deep heat and massage can be added for their “hands-on” appeal. A lumbosacral corset may be temporarily used. (There is no evidence that continued use of any brace promotes back weakness, however, especially if the patient adheres to an exercise program.) Recurrences are prevented by a proper exercise program and the avoidance of stress to the lower part of the back (Fig. 8-12).

Caudal or epidural cortisone injections are often very helpful. They may help relieve residual radicular pain. They tend not to relieve axial spine pain and may have no effect on acute leg pain if there is persistent nerve root compression from herniated or extruded disc material.

The prognosis for full recovery is excellent, and the majority of patients with disc herniation will improve with conservative treatment. Mild axial spine pain may recur on a sporadic basis indefinitely, however. Most of the time, this can be managed with mild analgesics and physical therapy. Motivation and reassurance are important. Keeping the patient active and comfortable can be difficult and challenging. What happens to the disc material that has herniated is unknown. It is theorized that it may act as a foreign body and be invaded by granulation tissue. Ultimately, the material may be absorbed or transformed into scar tissue. Larger herniations may actually regress the most.

Disc removal is reserved for those patients with major or progressing neurologic deficits or those with intractable leg pain who fail to respond to conservative management for at least 6 weeks. Of those patients with radicular leg pain documented by radiographic studies, fewer than 5% require surgery to relieve their symptoms. The patient must understand that disc removal is performed to relieve leg pain and that it has no effect on axial spine pain.

There are several ways of removing disc tissue, but the results of surgery are influenced more by patient selection that by the manner that the disc is removed. With a positive history, physical findings, myelography (or similar study), and EMG, there is a 90% to 95% success rate for surgery. In the absence of one or more of these, the cure rate for disc removal by any means declines considerably. Patients must also be cautioned that although their leg pain will usually disappear postoperatively, some mild intermittent low back pain may persist.

CHRONIC LUMBAR DISC DISEASE

A high percentage of adults older than 40 years of age have degenerative disc disease at one or more levels on roentgenographic examination (Fig. 8-13). Significant thinning of the disc accompanied by osteophyte formation is often present. And MRI studies commonly reveal “bulging” disc abnormalities in patients, many of whom are without symptoms. These roentgenographic changes are common in the general population and are present in 30% to 40% of normal individuals. They are so common, in fact, that some question whether or not lumbar disc disease should be considered a “disease” or simply a change which occurs with age. Disc degeneration and the accompanying changes in the adjacent facet joints with soft tissue inflammation can, however, lead to intermittent low back pain and even nerve root irritation or compression with leg pain. The severity of the symptoms often bears no relation to the severity of the radiographic findings, however.

Pain of this nature usually responds to conservative management. NSAIDs, analgesics, rest, moist heat, and the use of a lumbosacral corset may be the only treatment necessary. Exercises, education, and postural training are important. Risk factors associated with chronic back pain should be addressed, such as smoking and poor physical conditioning. A physical therapist can be helpful in this regard. When signs of nerve root irritation with radicular pain are present, compression or irritation of the root by a small, acute, soft disc herniation or degenerative osteophyte should be suspected. The leg pain often responds well to epidural pain blocks. Surgical intervention is occasionally indicated to relieve nerve pressure. Arthrodesis of the adjacent vertebrae may rarely be indicated to relieve chronic low back pain by stabilizing the degenerated painful disc segment but the procedure is highly controversial (see Chapter 18). Conservative treatment is usually successful in most cases. Recurrences are not uncommon and generally respond to medical management.

LUMBAR SPINE STENOSIS

Lumbar spinal stenosis is a syndrome in which narrowing of the spinal canal and nerve root foramina occurs, thus decreasing the space available for the neural elements; this may lead to vague and unusual symptoms. The disorder occurs secondary to a combination of disc degeneration, facet joint arthritis, and subluxation and occasionally to a congenitally small spinal canal. These changes can lead to abnormal pressure on spinal nerve roots.

CLINICAL FEATURES

The history is highly suggestive. Neurogenic claudication is a hallmark symptom. Low back pain, motor weakness, leg cramping (pseudoclaudication), and a sensation of “poor circulation” in the extremities are typical. The patient is usually older than 50 years of age. The symptoms are characteristically aggravated by walking and by extension of the lumbar spine. Improvement usually occurs with rest or flexion of the back. While grocery shopping, the patient often leans forward onto the cart to relieve the leg pain. These symptoms are often misinterpreted as being vascular in origin. Vascular symptoms will improve with rest, however, whether the patient is standing or sitting, but the patient with neurogenic claudication usually requires sitting because the forward flexed position increases the cross-sectional area of the bony canal, thereby relieving the symptoms. Sphincter disturbances and muscle atrophy rarely may be present. Physical findings typical of disc herniation are usually absent. Neurologic findings are also frequently minimal, and results of a straight-leg–raising test are usually normal. Pain on extension of the lumbar spine may be severe. The vascular examination is usually normal, but because vascular disease and stenosis occur in similar age groups and can produce similar symptoms, vascular studies may be necessary in some cases to differentiate the two conditions.

Roentgenographic examination of the lumbar spine usually reveals degenerative changes throughout the lower part of the back. EMG and myelography may help localize the disorder, and CT scanning is frequently diagnostic (Fig. 8-14). MRI is also helpful.

Lumbar Strain

Acute muscular or ligamentous injury is a common cause of low back pain. Incomplete muscular tears or ligament sprains occur and lead to pain and tenderness over the affected area. The simple acute injury usually heals quickly and should respond well to brief rest and symptomatic treatment. When the injury is superimposed on a chronic pattern of low back pain or lumbar disc disease, the course is often more protracted, however. When there is a delay in the normal recovery time of the simple soft tissue injury, other problems may have to be considered, particularly those related to the disc. And because of the common findings of incidental disc abnormalities in the normal population, the relevance of these radiographic findings in cases of low back strain is difficult to establish.

Many patients who sustain what appear to be seemingly minor low back strains fail to improve. A variety of factors are probably involved. Obesity, poor muscular tone, smoking, faulty work habits, the wearing of high-heeled shoes, and the lack of a daily exercise program are among the contributing factors. The center of gravity of the body may become shifted forward, which leads to an increase in the lumbar lordosis. This may place an added strain on the discs, ligaments, and muscles to maintain an upright posture. Chronic back pain is also frequently seen in teenagers who are vigorous weightlifters.

Smoking has a clear connection with low back pain. Smokers have a higher incidence of chronic back problems and recover more slowly from injuries. Microcirculatory factors are probably involved.

Obesity contributes to chronic low back pain in other ways. First, it is known that intraabdominal pressure aids the erector spinae muscles in keeping the lumbar spine erect and decreases intradiscal pressure. Obese patients have poor abdominal muscular tone. Obese patients also typically have an increase in their lumbar lordosis, which further adds stress to the lower part of the back.

With a daily program of proper postural exercises, weight loss, and a general exercise program, most patients who develop chronic back pain will be able to rehabilitate the lower part of the back. The use of modalities (hot packs, massage, etc.) in physical therapy is discouraged, although short-term use may allow the exercise program to be more easily implemented. Full cooperation is necessary.

NOTE: The term lumbar strain is often used as a “wastebasket” diagnosis. An exact diagnosis of low back pain in many cases of this nature may be difficult. Muscle strain, ligament sprain, and mild early disc herniation or degeneration may all present with similar clinical findings. Regardless of the cause, the initial treatment is the same. A short period of rest (1 to 2 days) and mild analgesics followed by a gradual return to activities may be all that is needed. Early return to normal activities is important. Walking or other similar aerobic exercise is started promptly to prevent deconditioning (generalized cardiovascular and musculoskeletal deterioration). Patients with chronic back pain benefit from postural back exercises and correction of obesity. Relaxation techniques are sometimes helpful. Active participation by the patient is most important. Passive care (massage, manipulation, etc.) has very little long-term benefit. Proper lifting and bending habits are stressed.

Isthmic Spondylolisthesis

Spondylolisthesis is a disorder, usually in the lumbar spine, in which one vertebra gradually slips on another. Several types have been described (congenital, degenerative, pathologic, traumatic, and spondylolytic). However, most spondylolisthesis is secondary to spondylolysis, which represents a fibrous defect in the pars interarticularis or isthmus of the vertebra (Fig. 8-15). The disorder is therefore probably acquired and not congenital. The development of this defect has a hereditary predisposition and usually becomes manifested as the result of impact loading and extension stresses to the lower part of the back. These cause the development of an overuse fatigue fracture, usually bilateral, at the isthmus that fails to heal, resulting in a fibrous nonunion. It is most common at L5-S1. It develops in the teenage years, but may not become symptomatic until years later, if at all. It is often associated with lumbosacral anomalies such as transitional vertebrae and spina bifida occulta. There is an increased incidence in football players and gymnasts, possibly from hyperextension and chronic overload. If the defect is bilateral, forward displacement (spondylolisthesis) can occur. Spondylolisthesis is classified according to the amount of forward slippage of the affected vertebra (Fig. 8-16). An increase in slippage often occurs during the adolescent growth spurt but is rare after maturity.

CLINICAL FEATURES

Spondylolysis may be symptomatic even without spondylolisthesis, and both conditions may be associated with lumbar disc herniation. The disorder is often asymptomatic, however, and is frequently discovered incidentally in adults on roentgenograms taken for other purposes. When it is seen on roentgenograms taken as a part of a routine evaluation for back pain, it is often difficult to determine whether or not it is playing any role in the patient’s complaints.

Symptoms from spondylolisthesis may begin gradually in the second or third decade. Low back pain, sometimes radiating into the buttocks, occurs with activity and is relieved by rest. If the lesion is acute, symptoms of nerve root irritation may also be present, along with radiation of the pain into the extremities. These symptoms often progress in severity, especially in the teenager.

Examination may reveal guarding of the lower part of the back and “spasm” of the paraspinal muscles, especially in the adolescent. Many children have no pain, however, but present with postural deformity or an abnormal gait pattern resulting from hamstring tightness. With moderate forward slippage, the lumbar lordosis appears increased, and the buttocks may appear more prominent. A palpable “step-off” in the spinous processes of the lumbar spine may be present. There may be tenderness in the affected area and hamstring tightness. Neurologic deficits are rare.

Roentgenograms reveal the typical findings of a defect in the pars interarticularis on both sides, which may be accompanied by forward slippage (Fig. 8-17). Unilateral defects are unusual. The classic findings of periosteal new bone present in stress fractures of long bones are rarely seen in the spine. A bone scan may be positive if the lesion is “acute” in the adolescent. MRI may be indicated in cases of negative bone scan to rule out other causes of pain. CT is also helpful to assess healing potential.

DEGENERATIVE SPONDYLOLISTHESIS

This type of spondylolisthesis results from disc degeneration and narrowing. When the process of disc “settling” is uneven, spondylolisthesis can develop (Fig. 8-18). The signs and symptoms are those of degenerative disc disease, sometimes accompanied by those of stenosis. Although many patients are pain-free, low back and occasionally radicular leg pain may develop. The treatment is the same as that for chronic degenerative disc disease and stenosis.

Back Pain in the Workplace

Work-related low back pain is a growing problem in industrial societies, not only from a medical standpoint, but also because of its legal and socioeconomic aspects. Low back pain accounts for as much as 25% to 30% of workers’ compensation payments and the majority of long-term disability cases.

A variety of terms have been used to describe this condition, including “chronic benign industrial back pain” and “chronic pain syndrome.” This terminology partly reflects the difficulty in assigning a specific diagnosis and cause for the pain. A part of this difficulty, in turn, is a result of the fact that low back pain in general, and especially back pain in the workplace may be the result of a variety of biomechanical, biochemical, behavioral, socioeconomic, and psychophysiologic factors. In addition, trying to distinguish between a work injury and a normal disease of life can have profound implications for the patient.

SPECIAL STUDIES

All of the anatomic structures of the lower part of the back (discs, ligaments, facet joints, bone, and muscle) can be the source of pain. The intervertebral disc is thought by many to be the source of most low back pain. Unfortunately, as many as 35% of asymptomatic adults will have abnormal findings on myelography, CT, or MRI that are usually related to the disc. This makes evaluation of this problem difficult, and it is felt by many that in the majority of cases, the exact underlying pathology probably cannot be determined and the condition is simply called “idiopathic.” Initially, a routine roentgenographic examination should be performed in 2 to 4 weeks if the patient does not improve, mainly to rule out any serious disorder. Further studies (EMG, CT, MRI, bone scan, myelography) should be performed only as adjuncts to the physical examination and history. The yield of clinically useful information from these studies is often poor. Subjecting patients to further extensive testing in a search for the exact etiology of their pain is likely to be futile, sometimes painful, and always costly. Diagnosing a spinal disorder solely on the basis of any of these tests should be avoided. It is rare that these special tests clearly demonstrate a source for the pain when it is not suspected clinically. In addition, any treatment (e.g., surgery) based solely on a special study will often fail. In general, myelography and other special studies should be used only under the following circumstances: (1) if surgical disc removal is contemplated for intractable leg pain or a serious neurologic deficit, or (2) if other serious spinal abnormality is suspected.

TREATMENT AND PROGNOSIS

Considerable controversy exists regarding the treatment of this problem. Historically, the disorder has always been resistant to traditional medical care. Thus, there has been a proliferation of rehabilitation services, pain centers, work-hardening programs, surgical procedures, chiropractic care, and physical therapy services. Patients often prefer this type of “hands-on” treatment, but no scientific proof exists that any of these treatments is any better than nature’s own. And although orthopedic and neurologic surgeons are commonly called on to assess and treat this condition, in fewer than 1% of these cases is surgery ever indicated (usually for leg pain associated with severe disc herniation), and not for at least 6 to 8 weeks. Surgery may even become a negative factor for returning the patient to work in that it gives validity to the injury.

Fortunately, the natural history of most back problems is that they improve and the end result of conservative management is usually good. Unfortunately, the longer the patient is away from work with benign low back pain, the less likely it is that the patient will ever return to gainful employment, and after 6 months of not working, the chance that the patient will return to any work is minimal. Thus, for a number of reasons, the trend for managing this condition has changed. There has been a de-emphasis on the initial rest period and more encouragement to early exercise and returning to work on a limited basis. This trend has developed largely because of the low success rate with prolonged bed rest and the belief that it causes a deterioration of the musculoskeletal and cardiopulmonary systems (deconditioning). It has also been shown that patients who begin exercise programs quickly after minor low back injuries have less pain and are disabled for shorter periods of time. (Only the patient with nerve root impingement because of disc herniation may require more rest.) The following approach may be helpful:

It is important for the treating physician to remain the patient’s advocate but to be objective at the same time, a situation that often results in conflict. Patients should be made to understand that the pain may recur if they resume light work, but it is usually not as severe as it was initially and does not mean any damage is occurring. It should not require further time off from work. The patient should continue the exercise program and practice good body mechanics. (A formal education program may be necessary.) Active participation by the patient and compliance are extremely important.

If no improvement has occurred after 4 to 6 weeks, referral to a specialist is indicated. Psychosocial factors and work-related conditions may also need investigation. The attitude of the patient to the job and involvement of the employer also play important roles in the length of disability. Workers who like their jobs and employers who promote a good working environment are more likely to have a mutually satisfactory relationship.

Scoliosis

Scoliosis is a general term used to describe a lateral curvature of the spine in the upright position. The lateral curvature is usually accompanied by some rotational deformity and sometimes by an increase in the normal kyphosis or lordosis. Scoliosis may be classified as either structural or nonstructural. Structural curves are fixed and nonflexible and fail to correct with side bending. Nonstructural curves, on the other hand, are flexible and readily correct with side bending. Nonstructural scoliosis is frequently seen as a compensatory mechanism secondary to a leg length discrepancy, local inflammation, or irritation from acute lumbar disc disease. This type of scoliosis tends to disappear when the offending disorder is treated, such as correcting a leg length inequality with a lift in the shoe.

Structural scoliosis may occur from a variety of causes. Congenital abnormalities in the spine with anomalous vertebral formation may lead to asymmetric growth and result in scoliosis. Neurofibromatosis and a variety of neurologic and myopathic conditions may also lead to structural scoliosis. The most common type, however, has no known cause and is usually termed “idiopathic.”

Idiopathic scoliosis accounts for approximately 90% of all scoliosis. The etiology is probably multifactorial. It appears to represent a hereditary disorder, but the exact mechanism of its production is unknown.

CLINICAL FEATURES OF IDIOPATHIC SCOLIOSIS

Genetic or idiopathic scoliosis usually appears clinically between the ages of 10 to 13 years, but may be seen at any age. By definition, the curve must be greater than 10 degrees. (This has been used historically because 10 degrees is the limit that can be detected by clinical examination.) It is six times more common in females, and serious curvatures are also more frequent in females. Right thoracic curves are the most common. In young people, the disease is usually asymptomatic, and subjective complaints are absent. (Pain should suggest tumor or other disorder.) Many cases are diagnosed by nurses in screening clinics or by other family members. Idiopathic scoliosis is sometimes classified according to age of onset (infantile, juvenile, adolescent) or by curve pattern. The adolescent type is most common. Prevalence is 1% to 3% of the general population.

The diagnosis is usually made on routine physical examination. Attention should be focused on the problem in all children, but especially in those between the ages of 10 to 14 years, when spinal growth is most rapid. For the examination, the patient should be undressed to the waist or wear a bathing suit, and a routine should be followed. The shoulders and iliac crests are inspected to determine whether they are level. The scapulae, rib cage, and flanks are then observed for symmetry. The spinous processes are palpated to determine their alignment. The patient is then asked to bend symmetrically forward at the waist with the arms hanging free (Fig. 8-19). Observation from the back or front will detect the spinal rotation in the form of a rib hump or abnormal paraspinal muscular prominence. Height measurements are taken initially and at all follow-up visits to gauge the growth rate of the patient and assess the risk of rapid progression of the curve. Additional data should be obtained regarding skeletal and sexual maturity (onset of menses, etc.).

The diagnosis is confirmed, and the degree of curvature is measured by a standing roentgenogram of the spine (Fig. 8-20). There is no other method of determining the severity of the curve, and a patient should never leave the office without an accurate roentgenographic measurement of the curvature. The roentgenogram may have to be repeated at intervals to determine whether or not the curve is progressive. Breasts and gonads should be shielded when films are done. The degree of skeletal maturity can be determined by assessing the status of the iliac apophysis using the Risser sign (Fig. 8-21).

MRI is usually not indicated unless there is some evidence for a secondary cause of the curve: (1) significant pain, (2) abnormal neurologic symptoms or findings, (3) a left thoracic curve (which is often associated with an underlying spinal disorder), or (4) rapid progression.

TREATMENT

The most important aspect in the treatment of scoliosis is early detection. Although the cosmetic appearance is the patient’s greatest concern, cardiopulmonary dysfunction has the most serious physical impact. A curve that is obviously visible when the patient is standing is often already approaching 30 to 40 degrees. Detecting a curve before it reaches 20 degrees is important because curves greater than 20 degrees tend to progress in the young. Prompt referral of all scoliosis patients to a specialist is mandatory. Frequent reexaminations are essential while the child is at an age where progression is common. The failure to diagnose or treat this problem early may result in progressive deformity, pain, cardiopulmonary compromise, and disability. Early discovery and treatment can prevent this progression.

The treatment depends on the age of the patient and the severity of the curve (Fig. 8-22). In the immature patient, frequent observation is necessary until the curve reaches 20 degrees. Curvatures more than 20 to 25 degrees may require treatment, depending on age and maturity. (The older child whose growth has slowed might only be observed if the curve is not excessive.) The curve can be stabilized and, in some cases, improved by spinal bracing, but full, permanent correction is not possible or necessary. The Milwaukee brace or a thoracolumbosacral orthotic (TLSO) is commonly used for this purpose (Fig. 8-23). The newer underarm orthotics are more easily accepted by the young patient because of their low-profile design. Treatment in the brace is continuous for 23 hours a day, and the brace may have to be worn for 2 years or longer. Exercises are performed in the brace to improve the cosmetic appearance and decrease the curvature, although the family needs to understand that the treatment will not eliminate the curve. Exercises alone will produce no change in the curvature, nor will they prevent any progression without the brace. Excellent results are obtained with proper use of the brace in curvatures between 20 and 40 degrees. It will not fully correct the curve, but it will usually prevent the curve from progressing to the stage where spinal surgery is necessary. Curves greater than 45 degrees cannot be effectively braced. Thus, early detection and treatment are important. Successful nonsurgical management maintains the spinal flexibility that spinal fusion eliminates.

Surgery is generally reserved for those cases in which the curvature is more than 45 to 50 degrees. Correction of the entire curvature by intraoperative instrumentation and maintenance of the correction by spinal fusion along the entire length of the curve are usually performed. This may be preceded by corrective casts or traction. Surgical success rates are high, but the loss of spine motion can create limitations for the patient.

In the adult, the spinal deformity may progress and eventually become painful, although the rate of back pain is similar to the general population. The assessment and treatment are essentially the same as it is for the common idiopathic nonspecific low back pain seen in conjunction with degenerative disc disease. Occasionally, instrumentation and spinal fusion may be indicated in these cases, but surgical intervention in the adult with benign back pain is controversial, and conservative treatment remains the mainstay of treatment.

Surgery for the cosmetic deformity alone involves major rib reconstruction. It is usually not recommended, although a few centers have had experience with the procedure.

Female patients with curves greater than 25 degrees may experience a few degrees of increase in their curve with each pregnancy. In most patients, however, neither pregnancy nor delivery is complicated by the presence of scoliosis.

Kyphosis

The mild curvature of the spine in the sagittal plane in which the convexity is directed posteriorly is termed kyphosis. This curvature exists in the normal spine at the thoracic and sacral regions. Abnormal thoracic angulation can occur from several pathologic states. Diseases of the discs and vertebral bodies are the most common causes. Congenital kyphosis is rare and is usually secondary to a localized malformation of the spine. An increase in kyphosis typically accompanies multiple compression fractures due to osteoporosis. Additional causes include radiation, surgery, and trauma.

SCHEUERMANN’S DISEASE

Scheuermann’s kyphosis is a fixed kyphosis that develops near the time of puberty. The cause is unknown, but the deformity is caused by typical wedging abnormalities in the dorsal and dorsolumbar spine that result in a decrease in the anterior height of the vertebrae. Mild forms may clinically resemble postural round back.

Discitis (Vertebral Osteomyelitis)

Discitis is a bacterial infection of the disc space and adjacent vertebral end plates. The process can occur anywhere in the spine but most often affects the midlumbar spine of children at the age of about 6 years. The disc space is more vulnerable in the young child because it is more vascular. A history of trauma or infection elsewhere may be present. Occasionally, the adjacent vertebral body is involved and abscess formation may even occur.

Seronegative Spondyloarthropathies

These conditions comprise a group or spectrum of interrelated disorders that are distinct entities but which share several clinical, roentgenographic, and genetic characteristics in common. One common specific feature is inflammation (enthesitis) and pain (enthesiopathy) at sites of tendon or ligament insertion. (An enthesis is the junction of ligament to bone.) Synovitis of the sacroiliac joints is also common. Nonarticular inflammation of varying degrees may also involve the eyes, skin, mucous membranes, bowel, and heart.

These disorders are typically seronegative for the rheumatoid factor. It is sometimes difficult to differentiate among them because they may occur simultaneously. They have been sometimes called rheumatoid variants. The spondyloarthropathies consist of four diseases: (1) ankylosing spondylitis, (2) psoriatic arthritis, (3) the arthritis associated with inflammatory bowel disease, and (4) Reiter’s syndrome and other forms of reactive arthritis.

These diseases may even present before the age of 16. In this age group, they are often called juvenile spondyloarthropathies and must be distinguished from juvenile rheumatoid arthritis and other forms of childhood arthritis. Peripheral joint involvement is more common in the young.

The cause of these conditions is unknown, but there is increasing evidence that the inflammation and destruction of bone and cartilage that occur in many rheumatic diseases are the result of the activation, by some unknown mechanism, of proinflammatory cells that infiltrate the synovium. These cells, in turn, release various substances, such as cytokines and tumor necrosis factor (TNF) alpha, which subsequently cause the pathologic changes typical of this group of diseases. Many of the newer therapeutic agents are directed at the suppression of these final mediators of inflammation.

ANKYLOSING SPONDYLITIS

Ankylosing spondylitis is a chronic inflammatory condition of the joints of the axial skeleton that characteristically manifests itself by morning stiffness in the low back and progressive loss of spinal movement. It is the oldest and most easily recognized of the spondyloarthropathies. The disorder is 10 times more common in men and is frequently familial. Bilateral sacroiliitis is the classic lesion. Inflammation of the entheses gradually leads to local ossification and ankylosis. The sacroiliac and spinal apophyseal joints are usually involved first, and the disorder commonly has its onset between the ages of 15 and 30 years. The disorder is also known as Marie–Strumpell disease.

An early diagnosis is often difficult because of the insidious onset of the disease. Years may pass between the onset of symptoms and the ultimate diagnosis because of the frequency of nonspecific back pain from other disorders. The pain is usually located low in the buttocks and thigh region but rarely radiates into the calf or foot. Often the disease is mild, and there may be few systemic symptoms; however, in a severe form, fatigue, weight loss, anorexia, fever, and other systemic complaints may accompany the onset. A few patients have difficulty taking a full breath. Although peripheral joint involvement may be present before the development of pain in the sacroiliac region, the diagnosis can only be presumptive until the sacroiliac joints are involved to such a degree as to be demonstrated roentgenographically. Although this disease is more common in men, women who have ulcerative colitis have an extremely high incidence of developing this disorder.

DIFFERENTIAL DIAGNOSIS

The differential diagnosis of ankylosing spondylitis includes the other spondyloarthopathies and rheumatoid arthritis. Psoriatic arthropathy, although similar, usually has late involvement of the sacroiliac joints; involves both the small and the large joints, particularly of the upper extremity; and has very specific skin lesions associated with it. Although aortitis may occur in psoriatic arthropathy, urethritis is absent, as is pulmonary fibrosis.

Reiter’s Syndrome is similar to psoriatic arthropathy in that sacroiliac joint involvement usually occurs late. The small and large joints, particularly of the lower extremity, are affected, and skin lesions are usually specific. Uveitis may occur, and urethritis is present at least at some point in the illness. Aortitis may occur, but pulmonary fibrosis has not been reported.

The arthritis associated with inflammatory bowel disease usually involves the large joints, particularly hips and shoulders, and sacroiliitis may be present early in the illness. Skin manifestations may be nonspecific or pathognomonic. In the patient with chronic ulcerative colitis, the skin lesion of pyodermic gangrenosum is at least very suggestive of the chronic underlying illness. In chronic inflammatory bowel disease, uveitis may occur but is uncommon. Urethritis is usually not present, and aortitis is rare.

Rheumatoid arthritis usually affects the peripheral joints and is more common in females. The tenosynovium and bursae are also frequently involved with the inflammatory process. It rarely affects the axial skeleton.

TREATMENT

PSORIATIC ARTHRITIS

Psoriasis may occasionally be accompanied by an inflammatory arthritis that affects both the axial skeleton and the peripheral joints (see Chapter 14). Spondyloarthropathy develops in 20% to 40% of cases and can affect any part of the spine. Sacroiliitis is often present and may be asymmetric. The prevalent age is between 30 and 55 years. The skin disorder usually precedes the arthritis by several years. Males and females are equally affected. Between 5% and 10% of patients with psoriasis will develop arthritis, which is much more common in patients with severe skin disease. Peripheral arthritis is very common and is usually polyarticular, involving the small joints of the hands and feet, and although it often runs a benign course in many patients, a very destructive form can occur, especially in the hand (arthritis mutilans). Dystrophic changes in the nails with pitting and ridging develop in many patients with DIP involvement.

The HLA-B27 antigen is often positive in patients with axial involvement. Treatment is similar to other spondyloarthropathies.

REITER’S SYNDROME

This is a disorder of unknown etiology first described as a triad of nongonococcal urethritis, conjunctivitis, and arthritis. Many enteric and sexually acquired agents (e.g., Salmonella and Chlamydia) appear capable of inducing the disorder, which is now referred to as a form of reactive arthritis. This latter term denotes a sterile arthritis that develops in a joint as a result of an infection at a site distant from the inflamed joint itself. Reactive arthritis encompasses Reiter’s syndrome. It does not usually include the arthritis associated with other infectious agents such as those caused by Borrelia (Lyme disease) and Streptococcus (rheumatic fever).

The syndrome is often incomplete. Inflammatory eye disease (uveitis, conjunctivitis) may occur. Low back pain is common. Patients are usually young, and the joint symptoms generally appear within 3 to 4 weeks of the infection, but often there is no obvious evidence of previous infection. The lower extremities are mainly affected. Heel pain (enthesitis) from Achilles tendonitis or plantar fasciitis is common.

Sacroiliitis similar to that seen in ankylosing spondylitis is common. The HLA-B27 antigen is present in more 85% of cases, and the erythrocyte sedimentation rate is usually elevated. Lab is not very helpful. The offending agents are difficult to culture.

Symptomatic treatment including the use of NSAIDs is advised. The use of antibiotics is controversial, but many authorities recommend tetracycline for 10 to 14 days if urethritis is present. The arthritis is often self-limited and frequently resolves in a few months. The joint symptoms do not appear to be affected by the use of antibiotics. Persistent symptoms may require more complicated medical intervention in consultation with a rheumatologist.

Diffuse Idiopathic Skeletal Hyperostosis

This is a common disorder of unknown cause characterized by excessive ossification at ligamentous and tendinous attachment sites to bone. Diffuse idiopathic skeletal hyperostosis (DISH), sometimes called Forestier’s disease or ankylosing hyperostosis of the spine, is a condition primarily affecting men over the age of 60 years. Bony proliferation causes a characteristic pattern of excessive calcification and ossification that primarily involves the spine but may affect peripheral joints as well. The disorder resembles ankylosing spondylitis to some degree, but there is no evidence that the two disorders are related.

CLINICAL FEATURES

Many patients have had minor symptoms of DISH for years before the condition is diagnosed. The primary complaints are those of low-grade spinal stiffness and pain, although the symptoms and signs are often relatively minor despite extensive hypertrophic spur formation. The thoracic spine is most often affected, most commonly on the right side. The presence of large anterior cervical osteophytes may lead to dysphagia (Fig. 8-29). Cervical myelopathy may result from ossification of the posterior longitudinal ligament. Other potential sequelae include lumbar stenosis and serious cervical spinal cord injuries, often associated with minor trauma. Peripheral joint symptoms are usually mild, although heel and elbow pain are often the presenting complaints. Extraspinal manifestations also include an increased risk of heterotopic ossification There are no diagnostic laboratory tests.

The roentgenographic findings are those of bridging anterior osteophytes fusing at least four vertebral bodies while preserving disc space. The condition is differentiated from ankylosing spondylitis by lack of involvement of the SI and apophyseal joints and negative HLA testing. Elbow and heel radiographs often reveal osteophytes (enthesophytes). Bone scanning may show increased uptake in areas of involvement, sometimes resembling metastatic disease.

Treatment consists of NSAIDs and an exercise program (walking and stretching). Symptoms are usually mild. The rare case of myelopathy or dysphagia may require surgical intervention.

Multiple Myeloma

This disorder, sometimes called plasma cell myeloma, is a neoplastic proliferation of the plasma cell of the bone marrow that often presents with spine pain. It may present as a systemic process or, less commonly, as a “solitary” lesion. Multiple myeloma is found in increasing incidence in patients older than 40 years of age, and men are affected twice as often as women. It is usually associated with a rise in serum globulin content, often because of abnormal globulins. It is the most common primary tumor of bone.

ROENTGENOGRAPHIC FEATURES

The classic finding is the “punched-out” lesion with sharply demarcated edges (Fig. 8-30). Usually, multiple lesions are found, but in 10%, only a single skeletal defect may be present. Diffuse osteoporosis because of generalized demineralization is the only finding in about 25% of cases. The typical lesions may occur in any part of the skeleton but are most common in the spine, skull, ribs, and pelvis. Pathologic fractures are common. Intervertebral body collapse may result in nerve root or cord compression. Diffuse bony involvement may even result in hypercalcemia. Using the bone scan to assess the disorder is helpful, but a negative scan can be misleading. This tumor is often “cold” on a bone scan because of its rapid destruction. Plain films are often better for evaluation. CT and MRI are also helpful.

Osteoporosis

Osteoporosis is a systemic disorder of the skeleton characterized by low total skeletal bone mass and microarchitectural deterioration of bone tissue, with a consequent increase in bone fragility and susceptibility to fracture. It is a major global health problem and is an epidemic in United States. About 20% of postmenopausal white women in the United States have osteoporosis, and an additional 52% have low bone density at the hip. It is four times more common in women than men. Unfortunately, fewer than one third of the cases of osteoporosis have been diagnosed, and only one seventh of American women with osteoporosis receive treatment. The disorder is the most common metabolic bone disease of the elderly, and as the population ages, the national health care cost for treatment will also rise dramatically. Once thought to be a natural part of aging among women, osteoporosis is no longer considered only age or gender dependent. It can be seen in men, amenorrheic athletes, and those with eating disorders. Because there are no warning signs until a fracture occurs, many patients are not diagnosed in time to receive effective therapy during the early phase of the disease. Fortunately, the condition is largely preventable due to the remarkable progress in the scientific understanding of its causes, diagnosis, and treatment.

Osteoporosis can have serious consequences. Elderly patients who experience hip fractures have a 12% to 20% mortality rate within the first year of fracture from related complications. Approximately one third of the rest will not be able to return to previous living arrangements. Half of the patients who fracture a hip will never regain functional weight-bearing status after their injury. Complications from this disease can be prevented by attaining and maintaining maximum bone mass.

Osteoporosis is of multifactorial origin and is usually classified as primary or secondary. The primary type is the form most often seen in the older population. It is further classified as type I or II, although there is considerable overlap between the two forms. Type I develops as a result of estrogen loss, which allows increased osteoclastic bone resorption. Type II is the result of a slow, progressive decline in osteoblastic activity with normal aging. Unfortunately, the elderly female often suffers the effects of both.

The World Health Organization (WHO) has established an operational definition depending on BMD (bone mineral density), commonly expressed as a T-score (Table 8-4). A T-score represents a patient’s bone density expressed as the number of standard deviations (SD) above or below the mean BMD value of normal young adults. After menopause, all women should be evaluated clinically for osteoporosis risk to determine the need for BMD testing.

Table 8-4 World Health Organization Diagnostic Criteria for Women Without Fragility Fractures

Diagnosis BMD Criteria
Normal BMD value within 1 SD of the young adult mean
Osteopenia BMD value between −1 SD and −2.5 SD below the young adult mean
*Osteoporosis BMD value at least −2.5 SD below the young adult mean

BMD, Bone mineral density.

* Women in this group who have already experienced one or more fractures are deemed to have severe or “established” osteoporosis.

FACTORS AFFECTING BONE MASS

Bone growth occurs over the first decades of life, with the peak in total bone mass occurring at the end of the second or third decade. At skeletal maturity, the male peak bone mass is 10% to 15% greater than the female, and blacks have 10% more than whites. With the cessation of gonadal function, many females can experience a rapid loss of bone over a period of 3 to 5 years as a result of increased osteoclastic function. With progressive aging, there can also be a decline in osteoblastic activity as well.

A number of factors can influence peak bone mass or contribute to bone loss in the adult in addition to hormonal deficiency. In general, the more risk factors a woman has, the greater her likelihood of osteoporotic fracture (Table 8-5). Secondary osteoporosis can also result from a number of medical conditions and from complications from the use of several medications (Table 8-6).

Table 8-5 Major Risk Factors for Osteoporosis and Related Fractures in White Postmenopausal Women

Personal history of fracture as an adult (>40–45 year age)
History of fragility fracture in a first-degree relative
Low body weight (<about 127 lbs)
Current smoking; alcohol more than two drinks per day
Use of oral corticosteroid therapy (>7.5 mg prednisone or its equivalent) for more than 3 months
Impaired vision, recent falls
Estrogen deficiency at an early age (<45 year) and prolonged premenopausal amenorrhoea (>1 year)
Dementia
Poor health/frailty/low physical activity
Low calcium intake (lifelong)

Table 8-6 Causes of Secondary Osteoporosis

Drugs (alcohol, steroids, heparin, anticonvulsants, cytotoxins, lithium, total parenteral nutrition, aluminum)
Disuse-prolonged immobilization
Malignancy (multiple myeloma,leukemia, lymphoma), mastocytosis
Endocrine disease (diabetes, thyroid disease, eating disorders, exercise-induced amenorrhea, Cushing’s syndrome, hyperparathyroidism).
Gastrointestinal disorders (gastrectomy, sprue, malabsorption syndromes, inflammatory conditions, liver disease)

The single greatest factor influencing a woman’s maximal or peak bone mass is genetics. Although all women become estrogen deficient at menopause, 80% of the variability in peak bone mass is attributable to genetic factors alone. The prevalence of osteoporosis, and incidence of fracture, vary by gender and race/ethnicity. White postmenopausal women experience almost three fourths of hip fractures and have the highest age-adjusted fracture incidence. However, women of other age, racial, and ethnic groups, and men and children, are also affected. African American women have higher BMD than white, non-Hispanic women throughout life and experience lower hip fracture rates; the bone densities for Mexican–American women are intermediate between the above two groups.

Both men and women experience an age-related decline in BMD starting in midlife. Women experience more rapid bone loss in the early years following menopause, which places them at earlier risk for fractures. Men and perimenopausal women with osteoporosis more commonly have secondary causes for the bone loss than do postmenopausal women. Among men, 30% to 60% of osteoporosis is associated with secondary causes; the most common are hypogonadism, use of glucocorticoids, and alcoholism. In perimenopausal women, more than 50% have secondary causes, most often caused by hypoestrogenemia, glucocorticoids, thyroid hormone excess, and anticonvulsant therapy. In postmenopausal women, the prevalence of secondary conditions is thought to be much lower, but the actual proportion is not known. Glucocorticoid use is the most common form of drug-related osteoporosis.

Residents of nursing homes and other long-term care facilities are at particularly high risk of fracture. Most have low BMD and a high prevalence of other risk factors for fracture, including advanced age, poor physical function, low muscle strength, decreased cognition, and high rates of dementia, poor nutrition, and, often, the use of multiple medications.

Compromised bone health may also be seen in children and adolescents. Premature and low birth weight infants have lower than expected bone mass in the first few months of life, but the long-term implications are unknown. Glucocorticoids are now commonly used for the treatment of a variety of common childhood inflammatory and asthmatic diseases, and the bone effects of this treatment should be considered when long-term steroid use is required. Hypogonadal states in adolescent girls and young women, associated with strenuous athletic training (“female athlete triad” of amenorrhea, osteoporosis, and eating disorder), emotional stress, and low body weight have failure to achieve peak bone mass, bone loss, and increased fracture rates. Anorexia nervosa deserves special mention. Although hypogonadism is an important feature of the clinical picture, the profound nutrition-related factors are also critical as evidenced, in part, by the failure of estrogen replacement to correct the bone loss.

CLINICAL FEATURES

The disease is insidious in onset, with the clinical disorder preceded by asymptomatic silent bone changes over many years. Spontaneous vertebral fractures, which are the most common skeletal injuries resulting from osteoporosis, may develop early after menopause but osteoporosis is often discovered as an incidental roentgenographic finding. Approximately 50% of women older than 65 years of age have spinal compression fractures; about two thirds of the fractures are clinically unrecognized. These fractures develop first because the vertebral body is composed of cancellous bone, which undergoes loss earlier than cortical bone. Osteoporosis leads to fragility fracture from trauma or force equal to or less than that resulting from a fall from standard height that would not cause a normal bone to fracture. Sometimes sneezing or vigorous coughing precipitates a fracture in osteoporotic bone. Acute or chronic back pain, made worse by standing erect or occasionally even by lying flat, should raise suspicion of vertebral fractures in postmenopausal women. The acute pain with a fracture subsides over 2 to 3 months, but could linger as chronic low back pain due to increasing lumbar lordosis. This chronic pain subsides within 6 months unless multiple fractures produce a picture of constant pain. The pain is typically reproduced by deep pressure over the spinous process at the involved level. Neurological deficits are rare.

The midback vertebrae T12 to L3 are the most common fracture sites, followed by T6 to T9 (Fig. 8-31). The rare osteoporotic fracture in the upper thoracic spine may be indicative of an underlying malignant tumor and may necessitate MRI studies. There is little correlation between the degree of collapse of the vertebral body and level of pain. Overall, 20% of women experience another vertebral fracture after their first fracture. They are also at increased risk for nonvertebral fracture. Eventually, vertebral collapse may cause the characteristic loss of body height, protuberant abdomen, and dorsal thoracic kyphosis called “dowager’s” hump. After achieving maximum height, most midlife women and men will lose 1 to 1½ inches of height as part of their normal aging process, primarily as a result of shrinkage of interverbral disks. In otherwise asymptomatic women, a height loss greater than 1½ inches may be associated with compression fractures of vertebra(e). Excessive kyphosis may even allow the rib cage to shift downward leading to restrictive lung disease. This sagging also prevents comfortable expansion of the stomach after eating and causes early satiety, which further limits nutritional intake. A rib–pelvis distance of less than 2 fingers’ width and inability to touch the occiput to wall when standing against the wall suggests the presence of compression fracture.

In the early postmenopausal state, the incidence of fracture of the distal radius is also high. Because the femur is composed of both cortical and cancellous bone, hip fractures usually develop years later, after age 65. Most (80%) of all hip fractures are associated with osteoporosis. Oral alveolar bone loss (which can lead to tooth loss) is strongly correlated with osteoporosis. Even in women without osteoporosis, there is a correlation between spinal bone density and number of teeth. Overall tooth counts are easy to do, and a tooth count less than 20 should suggest the need for further screening for osteoporosis.

Osteoporosis may also alter the psychological state of the individual with changes in self-esteem, body image, and mood. The patient may become more apprehensive and fearful of activity as the potential of fracture lingers in her mind. Many patients experience severe depression.

EVALUATION

The following patients should undergo assessment for postmenopausal osteoporosis: (1) all women 65 years old or older; (2) all adult women aged 40 years and older with a history of fracture or fractures not caused by severe trauma (such as motor vehicle accident); and (3) younger postmenopausal women who have clinical risk factors for fracture. The evaluation should include a comprehensive medical examination, including a complete history and physical examination. Risk factors should be evaluated, and there should be an assessment of the patient’s reliability, understanding, and willingness to accept available intervention.

BONE DENSITY MEASUREMENT

Currently, there is no accurate measure of overall bone strength. BMD is frequently used as a proxy measure and accounts for approximately 70% of bone strength. There is a 50% to 100% increase in fracture risk for each SD decline in bone density (approximately 0.1 g/cm bone mass). Although low bone density reliably predicts the risk of fracture, increase in bone density in response to treatment does not demonstrate a direct correlation with a reduction in fractures. Therefore, a few percentage point differences achieved by various treatments have little clinical meaning. Keep in mind that because the rate of bone loss after menopause contributes equally to the risk of fracture as the total bone mass present at the time of the menopause, a normal bone density measurement at the time of menopause does not mean that the patient will not be at risk of fracture later in life.

The clinical relevance of a bone density measurement in a postmenopausal woman is estimated by using the T-score. For younger women, interpretation uses the Z-score. The T-score is the standard deviation between patient and average peak young adult bone mass. The more negative, the greater the risk of fracture. The Z-score is the SD between the patient and the average bone mass for same age and weight. A Z-score lower than −2.0 requires diagnostic evaluation for secondary causes other than post menopausal bone loss.

Dual-energy X-ray absorptiometry (DEXA) is the technical standard for measuring BMD. It provides good precision for all sites of osteoporotic fractures, it is faster to perform, and the radiation dose is much less than for the standard chest radiograph film. For high precision, the DEXA technique measures mostly at three sites of greatest interest: the radius, the hip, and the spine. However, for practical clinical use and screening, measurements are made at the spine and hip. A normal value at one site does not preclude low bone density at another site. Serial measurements are best made at least 1 year apart. Portable DEXA machines have been developed that measure the heel, forearms, and finger. The hip is the preferred site of measurement in most individuals, because it predicts the risk of hip fracture, the most important consequence of osteoporosis. In younger individuals, such as perimenopausal or early postmenopausal women, spine measurements may be the most sensitive indicator of bone loss. Bone spurs, which are frequent in osteoarthritis, tend to falsely increase bone density of the spine in older individuals.

Other Studies

CT is used primarily to measure the spine and rarely the bone in the forearm or tibia. Research into the use of CT for measurement of the hip is ongoing. The results obtained from CT are different from all others currently available, because this technique specifically analyzes trabecular bone in the vertebrae and can provide a true density measurement. Peripheral quantitative CT evaluation may allow an earlier and more precise assessment of skeletal changes, because trabecular bone changes more quickly than cortical bone. However, CT remains expensive, involves greater radiation exposure, and is less reproducible.

Because of its low cost and mobility, ultrasound is amenable for use as a screening procedure. T-score discrepancies exist between different central and peripheral bone density devices, however. Because few studies correlate peripheral device-derived T-score (other than the wrist) and the lifetime fracture risk, peripheral technologies currently cannot be used for true WHO classification. Peripheral site measurements (e.g., wrist and calcaneus) should be limited to the screening and assessment of fracture risk in lower-risk populations when DEXA is not available. They should not be used for definitive diagnosis of osteoporosis or to monitor response to therapy. The most reliable comparative results for serial measurements are obtained when the same instrument and, ideally, the same technologist are used.

In-patients with known or suspected vertebral fractures or with unknown loss of height, radiographs of the thoracic and lumbar spine are indicated to identify and confirm the presence of fractures. Radiographic studies are usually indicated to confirm fractures at other sites as well. The sensitivity and reliability of standard radiography to assess BMD are poor, and in the absence of vertebral fractures, this technique cannot be used to diagnose osteoporosis. At least 30% to 40% of bone must be lost before radiographic changes become apparent.

PREVENTION AND TREATMENT

The prevention and treatment of osteoporosis begins at youth and continues throughout life. Effective preventive strategies that can be implemented during skeletal development (infancy and childhood) and in later life are needed to minimize the physical, social, and economic consequences of osteoporosis. The goals of prevention programs are to (1) optimize skeletal development in the young and maximize the acquisition of peak bone mass that occurs at skeletal maturity; (2) prevent age related and secondary causes of bone loss; (3) preserve the structural integrity of skeleton; and (4) prevent fractures. These goals are met by promoting a diet with adequate calcium content, encouraging good general nutrition, promoting adequate vitamin D intake, regular weight-bearing exercise, and avoiding tobacco and caffeine. Exercise should always include lifting weights with the arms to improve the strength of those bones that commonly fracture in osteoporotic patients (radius and upper humerus). Young women should be discouraged from becoming overly concerned with the thin body image. A certain amount of extra weight may actually be healthy for the skeleton in both the young and old. As part of an annual gynecologic examination, all women should be counseled on the risks of osteoporosis and related fractures.

Additional measures include the following:

Identification of patients who have fallen or are predisposed to falling. Recommend hip protectors in those patients. Minimize their risk of falling by gait and balance training (see Chapter 18); anchoring rugs; minimizing clutter’ removing loose wires; using nonskid mats; installing handrails in bathrooms, halls, and along stairways; lighting hallways; adjusting dosage of drugs with sedative effects; identifying and treating sensory defects, neurological disease, and arthritis; and encouraging patients to wear sturdy, low-heeled shoes.

The goals of treatment of osteoporosis include preventing fractures, stabilizing or achieving an increase in bone mass, relieving symptoms of fractures and skeletal deformity, and maximizing physical function (e.g., halting progressive deformity). Candidates for treatment include (1) women with T-scores of −1.5 or below with at least one risk factor, (2) women in whom nonpharmacological preventive measures are ineffective (bone loss continues or low-trauma fractures occur), and (3) women with postmenopausal osteoporosis (i.e., women with low-trauma fractures and low BMD, and women with BMD T-scores of −2.0 and below). All patients being considered for drug treatment of osteoporosis should also be counseled on risk factor reduction and adherence to universal recommendations about calcium, vitamin D, and exercise. Before initiating treatment, patients should be evaluated for secondary causes of osteoporosis and have central DEXA measurements, when available.

MANAGEMENT OF OSTEOPOROTIC FRACTURES

Hip fractures almost always require surgical repair if the patient is to become ambulatory again. Depending on the location and severity of the fracture, condition of the neighboring joint, and general status of the patient, procedures may include open reduction and internal fixation with pins and plates, hemiarthroplasties, and total arthroplasties. These surgical procedures are followed by intense rehabilitation in an attempt to return patients to their prefracture functional level. Long-bone fractures often require either external or internal fixation. Other fractures (e.g., vertebral, rib, and pelvic fractures) are usually managed with only supportive care, requiring no specific orthopedic treatment.

For acutely symptomatic fractures, treatment with analgesics is required. A few small, randomized clinical trials suggest that calcitonin may reduce pain related to acute vertebral compression fracture. Short periods of bed rest may be helpful for pain management, but in general, early mobilization is recommended as it helps prevent further bone loss. Occasionally, use of a soft elastic-style brace may facilitate earlier mobilization. Muscle spasms often occur with acute compression fractures and can be treated with muscle relaxants and heat treatments. Various physical modalities, such as ultrasound and transcutaneous nerve stimulation, may be beneficial in some patients.

In some cases, compression fractures may also be treated by percutaneous injection of artificial cement (polymethylmethacrylate) into the vertebral body (vertebroplasty or kyphoplasty); this has been reported to offer significant immediate pain relief in the majority of patients. Long-term effects are unknown, and conclusions are based on observational studies in patients with severe persistent back pain from acute or subacute vertebral fractures. Kyphoplasty—unlike vertebroplasty—has the advantage of restoring lost height by inflating a balloon tamp within and between fracture fragments before injection of the cement. Inclusion criteria include the following: pain localized to fracture, pain refractory to medical management, or a fracture of less than 12 months. Exclusion criteria include the following: fracture extending into the posterior vertebral cortex, retropulsed fragment, cord compression, radiculopathy, coagulopathy, or discitis with osteomyelitis.

Management during the perifracture period must also consider blood clot prevention in patients who will have delayed ambulation, the avoidance of substances that may inhibit fracture repair (NSAIDs, nicotine, corticosteroids), and the frequent need for supplemental caloric intake. Physical medicine and rehabilitation can also improve function and lower disability and the risk of falls. Finally, since fewer than 5% of patients with osteoporotic fractures are referred for medical evaluation and treatment, more aggressive diagnostic and therapeutic intervention of this population will help to prevent subsequent fractures.

Hormone treatment

Hormone replacement therapy (HRT) is an established approach for osteoporosis treatment and prevention. Estrogen/hormone therapy (ET/HT) is approved by the FDA for the prevention of osteoporosis, relief of vasomotor symptoms, and vulvovaginal atrophy associated with menopause. Standard doses of estrogen can be administered transdermally or orally. The conventional wisdom was that an estradiol level of 40 to 60 pg/mL is required to protect against bone loss. It is now known that the amount of estrogen can have an impact, although it is very likely that some degree of protection is lost when doses are less than the equivalent of 0.625 mg conjugated estrogen. In the HOPE (Health, Osteoporosis, Progestin, Estrogen) trial, the lowest dose of 0.3 mg conjugated estrogen, either unopposed or combined with 1.5 mg medroxyprogesterone acetate, produced a gain in bone density. A lower dose of estrogen may be more acceptable with fewer side effects in elderly women. Patients electing to be treated with lower doses should have follow-up assessments for response with either bone density or urinary biochemical markers. Because of the risks, ET/HT should be used in the lowest possible doses for the shortest duration to meet treatment goals. Generally, estrogen or hormone therapy is believed to work best if it is started in the first 5 to 10 years after menopause.

While progestional agents are considered antiestrogenic, they have been reported to act independently, in a manner similar to estrogen, to reduce bone resorption. When added to estrogen, progestins can lead to an apparent synergistic increase in bone formation associated with a positive balance of calcium. The Women’s Health Initiative (WHI) showed a 33% reduction in vertebral fractures, a 33% reduction in hip fractures, and a 24% overall reduction of fractures with estrogen–progestin combination treatment. It also showed that combined estrogen–progestin treatment increased the risk of fatal and nonfatal myocardial infarction by about 29%, confirming data from other studies. Other important relative risks included a 40% increase in stroke, 100% increase in venous thromboembolic disease, 26% increase in risk of breast cancer, and a twofold increase in dementia. Benefits other than the fracture reductions included a 37% reduction in risk of colon cancer. It is important to note that the WHI findings apply specifically to hormone treatment in the form of conjugated equine estrogen plus medroxyprogesterone acetate.

Bisphosphonates

These drugs, also called diphosphonates, are synthetic analogues of pyrophosphate, a naturally occurring substance that is an inhibitor of bone resorption Alendronate and risendronate are two products most commonly used for prevention and treatment of osteoporosis and treatment of steroid-induced osteoporosis. Risendronate is as effective as alendronate for prevention of bone loss, provides similar protection against fractures, and is better tolerated. Weekly administration of bisphosphonates reduces side effects and produces similar increases in bone density compared with daily regimens. These drugs reduce the risk of fractures of the spine and nonvertebral sites such as the hips and wrists. In women with osteoporosis, alendronate (10 mg) adminsstration reduced the risk of all subsequent fractures by 30% and vertebral fractures by 50% in 3 to 4 years of treatment. The optimal duration of treatment has not been established. Safety data for longer than 7 years of treatment for alendronate and for more than 3 years for risendronate are not available.

The approved dosage of alendronate for prevention of bone loss in new postmenopausal women and for treatment of corticosteroid-induced osteoporosis in men and estrogen-replete women is 5 mg daily or 35 mg weekly. For treatment of established postmenopausal osteoporosis and for treatment of corticosteroid-induced osteoporosis in estrogen-deficit women, the dose is 10 mg daily or 70 mg weekly. Risendronate is given either as 5 mg daily or 35 mg weekly for both prevention and treatment of osteoporosis. Contraindications to the use of these drugs include hypersensitivity to the drugs, hypocalcemia, inability to follow the dosing regimen (i.e., inability to stay upright for 30 minutes after the medicine is given), and the presence of esophageal abnormalities that might delay the transit of the tablet (e.g., achalasia, stricture). It is relatively contraindicated in presence of upper gastrointestinal tract disease.

The new once-a-month bisphosphonate approved recently is ibandronate. It is given orally in a dose of 150 mg. It is also FDA approved for both treatment and prevention of osteoporosis. Zoledronate given once a year or palmidronate every 3 months parentally could be used when patients cannot tolerate oral bisphosphonates.

Teriparatide (Forteo)

This is the recombinant human 1–34 amino acid fragment of PTH. It is the only treatment besides fluoride that directly stimulates osteoblasts to form new bone. Given to postmenopausal women with osteoporosis in a once-daily, subcutaneous dose, teriparatide produces a greater increase in bone density and possibly a greater reduction in fractures compared with estrogen or alendronate. The approved dose of PTH has been shown to decrease the risk of vertebral and nonvertebral fractures in postmenopausal women by 65% and 54%, respectively, over a 19-month treatment period. Its use is limited by its route of administration and cost. The FDA has approved PTH for the treatment of postmenopausal osteoporosis and in men with idiopathic or hypogonadal osteoporosis who are at high risk for fracture or who have failed or been intolerant of previous osteoporosis therapy. After a short period of treatment, perhaps 1 to 2 years, the gain in bone can be maintained with one of the antiresorptive agents. Currently, it is approved for only a 2-year course of treatment. The recommended dose is 20 mcg subcutaneously daily. This dose should not be exceeded because it has been shown to cause osteosarcoma in rats in higher doses. It is contraindicated in patients with hypercalcemia, Paget’s disease of bone, patients with open epiphyses, patients with prior radiation treatment, unexplained elevation of alkaline phosphatase, bone metastasis, and in patients with osteosarcoma or chondrosarcoma.

Follow-up

There are currently no well-accepted guidelines for monitoring the treatment of osteoporosis. The American Academy of Clinical Endocrinology (AACE) recommends annual reevaluation, which should include interim history, complete medical examination (including breast and pelvic examination, mammography, and Papanicolaou test), and assessment of adherence to recommended program (calcium, vitamin D, exercise, and/or any pharmacological therapy). The patient’s stature and skeletal integrity should also be assessed, including radiographic examination of newly symptomatic osseous deformities. The therapeutic program should be reinforced and there should be periodic assessment of BMD (central).

When DEXA is used, a BMD difference between measurements must be in the range of 3% to 5% to be clinically significant. For patients with normal baseline BMD, consider a follow-up measurement every 3 to 5 years. Patients whose bone density is well above the minimal acceptable level may not need further BMD testing. For patients in an osteoporosis prevention program, perform a follow-up every 1 to 2 years until bone mass stability is documented. After BMD has stabilized, perform a follow-up measurement every 2 to 3 years. For patients on a therapeutic regimen, perform a follow-up measurement yearly for 2 years. If bone mass has stabilized after 2 years, perform a follow-up measurement every 2 years. Otherwise, continue with annual follow-up measurement until stability is achieved.

Biochemical markers of bone turnover may prove useful for treatment monitoring, but there is currently little hard evidence to support this concept. If these markers are used, a determination should be made before starting therapy and repeated 4 months after therapy is initiated. In general, a value 30% to 40% lower than the baseline is thought to be significant.

Other Forms

An unusual type of regional osteoporosis is so-called Sudek’s atrophy, a result of reflex sympathetic dystrophy that is commonly found in the hands and feet (see Chapter 18). This localized osteoporosis is characteristically associated with the other findings of RSD, such as swelling, excessive sweating, and pain. Bone scanning may reveal increased flow to the affected area, a finding that may confirm the diagnosis of reflex dystrophy.

Tumors of the Spine

METASTATIC BONE DISEASE

Bone is the third most common site for distant spread of neoplastic disease, behind only the liver and lung. The major sources are myeloma and breast, lung, kidney, prostate, and thyroid carcinomas. The tumor usually disseminates by the hematogenous route, frequently through Batson’s plexus, a vertebral venous system. Pain is the most common complaint and usually is caused by the expanding nature of the lesion and/or a pathologic fracture. There may be a referred or radicular element to the discomfort that gives the problem the appearance of a herniated disc. Night pain, aggravated or not relieved by rest, occurs frequently. With progression of the disease, neurologic dysfunction may progress to complete paralysis.

Roentgenographs often reveal the lesion, but 30% to 50% of the bone must be destroyed before the lesion is visualized on plain films. The bone scan is positive in 90% of cases. False negatives commonly occur in myelomas and many carcinomas because these tumors produce such rapid and extensive bone destruction that new bone formation and the reparative process do not occur. (Technetium scanning relies on bone repair.) CT and MRI scans will usually reveal the lesion.

Laboratory studies commonly reveal an elevated alkaline phosphatase level. Acid phosphatase levels are usually increased in prostate metastases. Serum calcium levels may also be elevated. Bone marrow aspiration or biopsy is usually necessary to establish the diagnosis.

Treatment of the skeletal metastasis depends on biopsy confirmation of the type of tumor that is present and the appropriate use of radiation therapy, chemotherapy, or hormonal therapy as indicated.

Back Pain from Other Origins

Visceral pain is often referred to the more posterior parts of the spine that innervate the diseased organ. In general, disease of the upper portion of the abdomen may refer pain to the shoulder and dorsolumbar spine; lower abdominal disorders refer pain to the lower lumbar spine; and pelvic disease refers pain to the sacrum. Usually, there are no findings related to the back, such as loss of motion.

ABDOMINAL DISORDERS

Peptic ulcer disease or tumor of the stomach or duodenum may induce pain in the lower thoracic and upper lumbar spine if the posterior wall is involved. If intense, the pain may radiate around to the front of the abdomen. The ulcer pain tends to retain its original character of response to antacids and food. Thoracolumbar and left shoulder pain referral is not uncommon from pancreatitis. The pain is often quite intense. Previous episodes may have occurred, and there is often a recent history of alcohol or dietary excess. Tumor and peptic ulceration with extension to the pancreas commonly cause back and flank pain. The patient may seek relief by bending forward. The pain is more likely to be to the left of the spine if the tail of the pancreas is involved and to the right if the head is involved. Nausea, vomiting, prostration, and diaphoresis are common; and the abdomen is usually distended and tender. There is often a leukocytosis and elevation of serum and urinary amylase levels.

An aneurysm of the aorta may cause not only acute abdominal pain and collapse with abdominal rigidity but also back pain (Fig. 8-32). Generally, the pain is thoracic but may be higher or lower depending on location. There may be an absence or reduction of pulses in one of the lower extremities, and a pulsatile mass is often present.

In addition to aneurysms, disorders of other retroperitoneal structures may evoke back pain. The pain commonly radiates to the lower portion of the abdomen, groin, labia, or testicles and anterior aspect of the thighs. Iliopsoas tumors or abscess, lymphomas, or acute bleeding resulting from anticoagulation may all produce symptoms sometimes confused with hip, back, or abdominal disorders. Frequently, there is pain with hip motion in extension but not in flexion because the iliopsoas is relaxed in flexion.

Colon disorders (tumor, colitis, diverticulitis) may cause pain felt in the lower portion of the abdomen, lumbar spine, and groin. Transverse colon lesions may refer to L2 or L3 and sigmoid lesions to the sacrum.

GENITOURINARY DISORDERS

Renal diseases are among the most common nonorthopedic disturbances to simulate back disease. The pain of renal colic, caused by the passage of a small stone, clot, pus, or crystals, is usually ipsilateral and felt in the flank and lumbar area. It often radiates into the corresponding groin and testicle or vulva. Vomiting and restlessness are common, and there may be frequency and pain on urination. It is sometimes accompanied by hematuria. A positive Murphy’s punch is diagnostic. Renal stones are rare in children, and when they occur, the patient should be evaluated for underlying metabolic disorders such as cystinuria. Acute pyelonephritis frequently causes low back pain, but systemic and urinary symptoms usually clarify the diagnosis. Chills, fever, urinary frequency and urgency, and pain and tenderness in the costovertebral angle are usually present.

Renal vein thrombosis may also present as back and flank pain. Compression or invasion by local or metastatic tumor, proximal extension of a distal thrombus, and severe dehydration are among the common causes. The presence of unexplained edema (especially if unilateral) and the development of collateral abdominal veins may suggest the diagnosis. Recurrent pulmonary emboli may also occur. Palpable enlargement of the kidney, hematuria, and proteinuria are usually present. The proteinuria sometimes leads to nephrotic syndrome.

Back pain occasionally accompanies prostate disorders. Prostatitis may evoke sacral pain, sometimes radiating into one leg. It is usually accompanied by frequency, and there may be prostatic discharge. Prostate carcinoma with metatases to the lower portion of the back is another cause of lumbar or sacral pain. Most prostatic disorders are diagnosed by rectal examination, which should always be performed, especially for those patients whose back pain is unexplained.

Low back pain is also a common complaint in gynecologic practice. Simple menstrual pain may cause low lumbar and sacral pain. It is frequently crampy and radiates down the legs. Uterine colic or dysmenorrhea may cause similar symptoms. Vomiting sometimes occurs. Pain from endometriosis may also cause cyclical discomfort. The menstrual history is often suggestive of these disorders.

Retrodisplacement of the uterus, especially if associated with retroflexion, may cause a nagging sacral pain, particularly after the patient has been upright for several hours. Tension on the uterosacral ligaments is the usual cause of back pain due to enlargement, tumors, or malposition of the uterus. Large posterior pelvic tumors may be painful because of pressure or involvement of the sacral plexus. Backache of this type in conjunction with pelvic malignancies (especially carcinoma of the cervix) usually indicates that the disease has advanced to involve the iliac nodes. This pain often becomes more severe and worse at night.

Pregnancy, ectopic or otherwise, should always be ruled out in women of childbearing years, especially if invasive or roentgenographic studies are being planned. A well-performed pelvic examination will help separate the majority of these disorders (Fig. 8-33).

BIBLIOGRAPHY

Ahn UM, Ahn NU, Nallamshetty L, et al. The etiology of adolescent idiopathic scoliosis. Am J Orthop. 2002;31:387-395.

Aho K, Ahvonen P, Lassus A, et al. HL-A antigen 27 and reactive arthritis. Lancet. 1973;2:157.

Andrade SE, Majumdar SR, Chan KA, et al. Low frequency of treatment of osteoporosis among postmenopausal women following a fracture. Arch Intern Med. 2003;163:2052-2057.

Ansell BM. Rheumatic disorders in childhood. Clin Rheum Dis. 1976;2:303.

Appelrouth D, Gottlieb NL. Pulmonary manifestations of ankylosing spondylitis. J Rheumatol. 1975;2:446-453.

Arnett FCJr. The implications of HL-A W27. Ann Intern Med. 1976;84:94-95.

Avioli LV. Osteoporosis, pathogenesis and therapy. In: Avioli LV, Vrane SM, editors. Metabolic bone disease. New York: Academic Press, 1977.

Avioli LV. Senile and postmenopausal osteoporosis. Adv Intern Med. 1976;21:391-415.

Avioli LV. Significance of osteoporosis: a growing national health care problem. Orthop Rev. 1992;21:1126-1129.

Bauer DC, Browner WS, Cauley JA, et al. Factors associated with appendicular bone mass in older women. Ann Intern Med. 1993;118:657-665.

Bargolie B, Epstein J, Selvanayagam P, et al. Plasma cell myeloma—new biological insights and advances in therapy. Blood. 1989;73:865-879.

Belanger TA, Rowe DE. Diffuse idiopathic skeletal hyperostosis: Musculoskeletal manifestations. J Am Acad Orthop Surg. 2001;9:258-267.

Bennett DL, Ohashi K, El-Khoury GY. Spondyloarthropathies: ankylosing spondylitis and psoriatic arthritis. Radiol Clin North Am. 2004;42:121-134.

Benson MKD, Byrnes DP. The clinical syndromes and surgical treatment of thoracic intervertebral disc prolapse. J Bone Joint Surg Br. 1975;57:471-477.

Bernat JL. A dangerous backache. Hosp Pract. 1977;12:36-37.

Bernstein DS, Sadowsky N, Hegsted DM, et al. Prevalence of osteoporosis in high and low fluoride areas of North Dakota. JAMA. 1966;198:499-504.

Bingham WF. The role of HLA B27 in the diagnosis and management of low back pain and sciatica. J Neurosurg. 1977;47:561-566.

Birdi N, Allen U, D’Astous J. Poststreptococcal reactive arthritis mimicking acute septic arthritis: a hospital-based study. J Pediatr Orthop. 1995;15:661-665.

Biyani A, Andersson GB. Low back pain: pathophysiology and management. J Am Acad Orthop Surg. 2004;12:106-115.

Black DM, Greenspan SL, Ensrud KE, et al. The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis. N Engl J Med. 2003;349:1207-1215.

Blount WP, Moe JH. The Milwaukee brace. Baltimore: Williams & Wilkins, 1973.

Blumberg B, Ragan C. The natural history of rheumatoid spondylitis. Medicine (Baltimore). 1956;35:1-31.

Boden SD, Davis DO, Dina TS, et al. Abnormal magnetic resonance scans of the lumbar spine in asymptomatic subjects. J Bone Joint Surg Am. 1990;72:403-408.

Boden SD, Weisel SW. Lumbar spine imaging: role in clinical decision making. J Am Acad Orthop Surg. 1996;4:238-248.

Bolender NF, Schonstrom NSR, Spengler DM. Role of computed tomography and myelography in the diagnosis of central spinal stenosis. J Bone Joint Surg Am. 1985;67:240-246.

Bondilla KK. Back pain: osteoarthritis. J Am Geriatr Soc. 1977;25:62-66.

Bough B, Thakore J, Davies M, et al. Degeneration of lumbar facet joints. Arthrography and pathology. J Bone Joint Surg Br. 1990;72:275-276.

Bradford DS, Moe JH, Montalvo FJ, et al. Scheuermann’s kyphosis. Results of surgical treatment by posterior spine arthrodesis in 22 patients. J Bone Joint Surg Am. 1975;57:439-448.

Brewerton DA, Caffrey M, Nicholls A, et al. Reiter’s disease and HL-A 27. Lancet. 1973;2:996-998.

Brown MD. Diagnosis of pain syndromes of the spine. Othrop Clin North Am. 1975;6:233-248.

Brown MD. Intradiscal therapy with chymopapain or collagenase. Chicago: Year Book Medical Publishers, 1893.

Buchanan JR, Myers C, Greer RB3rd, et al. Assessment of the risk of vertebral fracture in menopausal women. J Bone Surg Am. 1987;69:212-218.

Bulkley BH, Roberts WC. Ankylosing spondylitis and aortic regurgiatation. Description of the characteristic cardiovascular lesion from study of eight necropsy patients. Circulation. 1973;48:1014-1027.

Buttermann GR. Treatment of lumbar disc herniation: epidural steroid injection compared with discectomy. A prospective, randomized study. J Bone Joint Surg Am. 2004;86-A:670-679.

Calabro JJ, Amante CM. Indomethacin in ankylosing spondylitis. Arthritis Rheum. 1968;11:56-64.

Caldwell AB, Chase C. Diagnosis and treatment of personality factors in chronic low back pain. Clin Orthop. 1977;129:141-149.

Calin A. Raised serum creatine phosphokinase activity in ankylosing spondylitis. Ann Rheum Dis. 1975;34:244-248.

Carman DL, Browne RH, Birch JG, et al. Measurement of scoliosis and kyphosis radiographs. Intraobserver and interobserver variation. J Bone Joint Surg Am. 1990;72:328-333.

Carette S, Marcoux S, Truchon R, et al. A controlled study of corticosteroid injections into facet joints for chronic low back pain. N Engl J Med. 1991;325:1002-1007.

Chapuy MC, Arlot ME, Duboeuf F, et al. Vitamin D3 and calcium to prevent hip fractures in elderly women. N Engl J Med. 1992;327:1637-1642.

Cuellar ML, Espinoza LR. Management of spondyloarthropathies. Curr Opin Rheumatol. 1996;8:288-295.

Curtis P. Low back pain in the primary care setting. J Fam Pract. 1977;4:381-382.

David JR, Chamberlin E, Blackhurst DW. Indications for magnetic resonance imaging in presumed adolescent idiopathic scoliosis. J Bone Joint Surg Am. 2004;86:2187-2195.

Deen HGJr. Diagnosis and management of lumbar disk disease. Mayo Clin Proc. 1996;71:283-287.

Dickson RA. Conservative treatment for idiopathic scoliosis. J Bone Surg Br. 1985;67:176-181.

Duncan H, Frame B, Frost HM, et al. Migratory osteolysis of the lower extremities. Ann Int Med. 1967;66:1165-1167.

Dyck P, et al. Intermittent cauda equina compression syndrome. Spine. 1977;2:75.

Early SD, Kay RM, Tolo VT. Childhood diskitis. J Am Acad Orthop Surg. 2003;11:413-420.

Eisenstein SM, Perry CR. The lumbar facet arthrosis syndrome. Clinical presentation and articular surface changes. J Bone Joint Surg Br. 1987;69:3-7.

Eismont FJ, Currier B. Surgical management of lumbar intervertebral-disc disease. J Bone Joint Surg Am. 1989;71:1266-1271.

Engleman EG, Engleman AP. Ankylosing spondylitis. Recent advances in diagnosis and treatment. Med Clin North Am. 1977;61:347-364.

Fast A. Low back disorders: conservative management. Arch Phys Med Rehabil. 1988;69:880-891.

Feldstein AC, Nichols GA, Elmer PJ, et al. Older women with fractures: patients falling through the cracks of guideline-recommended osteoporosis screening and treatment. J Bone Joint Surg Am. 2003;85-A:2294-2302.

Ferris B, Edgar M, Leyshon A. Screening for scoliosis. Acta Orthop Scand. 1988;59:417-418.

Gabos PG, Bojescul JA, Bowen JR, et al. Long-term follow-up of female patients with idiopathic scoliosis treated with the Wilmington orthosis. J Bone Joint Surg Am. 2004;86-A:1891-1899.

Ginsberg GM, Bassett GS. Back pain in children and adolescents: evaluation and differential diagnosis. J Am Acad Orthop Surg. 1997;5:67-78.

Godfrey RB, et al. A double-blind crossover trial of aspirin, indomethacin and phenylbutazone in ankylosing spondylitis. Arthritis Rheum. 1972;15:110.

Gorman JD, Sack KE, Davis JCJr. Treatment of ankylosing spondylitis by inhibition of tumor necrosis alpha. N Engl J Med. 2002;346:1349-1356.

Greipp PR. Prognosis in myeloma. Mayo Clin Proc. 1994;69:895-902.

Guck TP, Meilman PW, Skultety FM, et al. Prediction of long term outcome of multidisciplinary pain treatment. Arch Phys Med Rehabil. 1986;87:293-296.

Haddad JGJr, Birge SJ, Avioli LV. Effects of prolonged thyrocalcitonin administration in Paget’s disease of bone. N Engl J Med. 1970;283:549-555.

Hart FD. The ankylosing spondylopathies. Clin Orthop Relat Res. 1971;74:7-13.

Harvey MA, James B. Differential diagnosis. Philadelphia: WB Saunders, 1972.

Heaney RP. A unified concept of osteoporosis. Am J Med. 1965;39:877-880.

Heaney RP. Nutrition and catch-up bone agumentation in young women. Am J Clin Nutr. 1998;68:523-524.

Hedequist D, Emans J. Congenital scoliosis. J Am Acad Orthop Surg. 2004;12:266-275.

Henley ENJr, Shapiro DE. The development of low back pain after excision of a lumbar disc. J Bone Joint Surg Am. 1989;71:719-721.

Hensinger RN. Spondylolysis and spondylolisthesis in children and adolescents. J Bone Joint Surg Am. 1989;71:1098-1107.

Hurley DL, Khosla S. Update on primary osteoporosis. Mayo Clin Proc. 1997;72:943-949.

Hurme M, Alaranta H. Factors predicting the result of surgery for lumbar intervertebral disc herniation. Spine. 1987;12:933-938.

Jackson RP, Jacobs RR, Montesano PX. 1988 Volvo award in clinical sciences. Facet joint injection in low-back pain. A prospective statistical study. Spine. 1988;13:966-971.

Jausey J, et al. Some results of the effects of fluoride on bone tissue in osteoporosis. J Clin Endocrinol. 1969;28:869.

Jayson MI, Bouchier IA. Ulcerative colitis with ankylosing spondylitis. Ann Rheum Dis. 1968;27:219-224.

Jonsson B, Stromquist B. Symptoms and signs in degeneration of the lumbar spine. J Bone Joint Surg Br. 1993;75:381-386.

Kataria RK, Brent LH. Spondyloarthropathies. Am Fam Physician. 2004;15:2853-2860.

Kertesz A, Kormos R. Low back pain in the workman in Canada. Can Med Assoc J. 1976;115:901-903.

Kiel DP, Felson DT, Anderson JJ, et al. Hip fracture and the use of estrogens in postmenopausal women. The Framingham Study. N Engl J Med. 1987;317:1169-1174.

Kostuik JP, Harrington I, Alexander D, et al. Cauda equina syndrome and lumbar disc herniation. J Bone Joint Surg Am. 1986;68:386-391.

Krupp MA, Chatton MJ. Current diagnosis and treatment. Los Altos, CA: Lange Medical Publications, 1972.

Lane JM, Nydick M. Osteoporosis: current modes of prevention and treatment. J Am Acad Orthop Surg. 1999;7:19-31.

Lane JM, Vigorita VJ. Osteoporosis. J Bone Joint Surg Am. 1983;65:274-278.

Lauterman WC, Cain JE. Isthmic spondylolisthesis in the adult. J Am Acad Orthop Surg. 1996;4:201-208.

Lee DH, Claussen GC, Oh S. Clinical nerve conduction and needle electromyography studies. J Am Acad Orthop Surg. 2004;12:276-287.

Lenke LG, Betz PR, Harms J, et al. Adolescent idiopathic scoliosis: a new classification to determine extent of spinal arthropathies. J Bone Joint Surg Am. 2001;83-A:1169-1181.

Leutwek L, Whedon GD. Osteoporosis. April 1963. DM

Macnab I. Backache. Baltimore: Williams & Wilkins, 1977.

Mac-Thiong 2004 Mac-Thiong JM, Berthonnaud E, Dimar JR2nd, et al. Sagittal alignment of the spine and pelvis during growth. Spine. 2004;29:1642-1647.

Mader R. Diffuse idiopathic skeletal hyperostosis: isolated involvement of cervical spine in a young patient. J Rheumatol. 2004;31:620-621.

Madore GR, Sherman PJ, Lane JM. Parathyroid hormone. J Am Acad Orthop Surg. 2004;12:67-71.

Maksymowych WP. Update on spondylarthropathy. Arthritis Rheum. 2004;51:143-146.

Malpas JS. Problems in the management of myeloma. Postgrad Med J. 1989;65:468-470.

Manniche C, Hesselsoe G, Bentzen L, et al. Clinical trial of intensive muscle training for chronic low back pain. Lancet. 1988;24:1473-1476.

McBryde AMJr, McCollum DE. Ankylosing spondylitis in women. The disease and its prognosis. N C Med J. 1973;34:34-37.

McCulloch JA. Chemonucleolysis. J Bone Joint Surg Br. 1977;59:45-52.

McEwen C, DiTata D, Lingg C, et al. Ankylosing spondylitis and spondylitis accompanying ulcerative colitis, regional enteritis, psoriasis, and Reiter’s disease. A comparative study. Arthritis Rheum. 1971;14:291-318.

McGoey BV, Deitel M, Saplys RJ, et al. Effect of weight loss on musculoskeletal pain in the morbidly obese. J Bone Joint Surg Br. 1990;72:322-323.

McKiernan F, Fasciszewski T, Jensen R. Quality of life following vertebroplasty. J Bone Joint Surg Am. 2004;86-A:2600-2606.

Meyerding HW. Spondylolisthesis. Surg Gynecol Obstet. 1932;54:371.

Miller GM, Forbes GS, Onofrio BM. Magnetic resonance imaging of the spine. Mayo Clin Proc. 1989;64:986-1004.

Moe JH, Kettleson DN. Idiopathic scoliosis. Analysis of curve patterns and the preliminary results of Milwaukee-brace treatment in one hundred sixty-nine patients. J Bone Joint Surg Am. 1970;52:1509-1533.

Montgomery SP, Erwin WE. Scheuermann’s kyphosis—long-term results of Milwaukee braces treatment. Spine. 1981;6:5-8.

Mooney V. Percutaneous discectomy. Spine. 1989;3:103.

Mooney V, Brigham A. The role of measured resistance exercises in adolescent scoliosis. Orthopedics. 2003;26:167-171.

Mooney V, Cairns D. Chronic low back pain: evaluation and therapy. Orthop Clin North Am. 1978;9:543-547.

Morrissy RT, Goldsmith GS, Hall EC, et al. Measurement of the Cobb angle on radiographs of patients who have scoliosis. Evaluation of intrinsic error. J Bone Joint Surg Am. 1990;72:320-327.

Murray PM, Weinstein SL, Spratt KF. The natural history and long-term follow-up of Scheuermann kyphosis. J Bone Joint Surg Am. 1993;75:236-248.

Nachenson AL. The lumbar spine, and orthopedic challenge. Spine. 1976;1:59.

Nash CLJr. Current concepts review: scoliosis bracing. J Bone Joint Surg Am. 1980;62:848-852.

Nelson MA. Lumbar spinal stenosis. J Bone Joint Surg Br. 1973;55:506-512.

Novak RE, Jones SG, Jones MW. Novak’s textbook of gynecology. ed 8, Baltimore: Williams & Wilkins, 1970.

O’Connor 1992 O’Connor MI, Carrier BI. Metastatic disease of the spine. Orthopedics. 1992;15:611-620.

Ogryzlo MA. Ankylosing spondylitis. In Hollander JL, McCarty DJJr, editors: Arthritis and allied conditions, ed 8, Philadelphia: Lea & Febiger, 1972.

Ogryzlo MA, Rosen PS. Ankylosing (Marie-Strumpell) spondylitis. Postgrad Med. 1969;45:182-188.

Papagelopoulos PJ, Petrou HG, Triantafyllidis PG, et al. Treatment of lumbosacral radicular pain with epidural steroid injections. Orthopedics. 2001;24:145-149.

Petrie SP, Mehrsheed S, Squires RW, et al. Physical activity but not aerobic capacity correlates with back strength in healthy premenopausal women from 29–40 years of age. Mayo Clin Proc. 1993;68:738-742.

Prestwood KM, Kenny AM, Kleppinger A, et al. Ultralow-dose micronized 17beta-estradiol and bone density and bone metabolism in older women: a randomized controlled trial. JAMA. 2003;290:1042-1048.

Radin EL. Reasons for failure of L5-S1 intervertebral disc excisions. Int Orthop. 1987;11:255-259.

Ramirez LF, Thisted R. Complications and demographic characteristics of patients undergoing lumbar discectomy in community hospitals. Neurosurgery. 1989;25:226-230.

Rasmussen-Barr 2003 Rasmussen-Barr E, Nilsson-Wikmar L, Arvidsson I. Stabilizing training compared with manual treatment in sub-acute and chronic low-back pain. Man Ther. 2003;8:233-241.

Recker RR, Saville PD, Heaney RP. Effect of estrogens and calcium carbonate on bone loss in postmenopausal women. Ann Intern Med. 1977;87:649-655.

Resnick NM, Greenspan SL. ‘Senile’ osteoporosis reconsidered. JAMA. 1989;261:1025-1029.

Riggs BL, Jowsey J, Goldsmith RS, et al. Short- and long-term effects of estrogen and synthetic anabolic hormone in postmenopausal osteoporosis. J Clin Invest. 1972;51:1659-1663.

Riggs BL, Melton LJ3rd. The prevention and treatment of osteoporosis. N Engl J Med. 1992;327:620-627.

Riggs BL, Melton LJ3rd. Involutional osteoporosis. N Engl J Med. 1986;314:1676-1686.

Riggs BL, Melton LJ3rd. Osteoporosis. Etiology, diagnosis, and management. New York: Raven Press, 1988.

Rosenberg E, Lang R, Boisseau V, et al. Effect of long-term calcitonin therapy on the clinical course of osteogenesis imperfecta. J Clin Endocrinol Metab. 1977;44:346-355.

Ruge D, Wiltse LL. Spinal disorders: diagnosis and treatment. Philadelphia: Lea & Febiger, 1977.

Schlosstein L, et al. High association of an HL-A antigen, W27, with ankylosing spondylitis. N Engl J Med. 1973;288:704.

Schurman DJ, Nagel DA. Low back and leg pain. Prim Care. 1974;1:549-563.

Sewell KL. Modern therapeutic approaches to osteoporosis. Rheum Dis Clin North Am. 1989;15:583-614.

Sim FH. Metastatic bone disease. Philosophy of treatment. Orthopedics. 1992;15:541-544.

Simons GW, Sty JR, Starshak RJ. Retroperitoneal and retrofascial abscesses. J Bone Joint Surg Am. 1983;65:1041-1058.

Simotas AC. Nonoperative treatment for lumbar spinal stenosis. Clin Orthop Relat Res. 2001;384:153-161.

Singer FR. Page’’s disease of bone. New York: Plenum Publishing Corp, 1977.

Smith L. Enzyme dissolution of the nucleus pulposus in humans. JAMA. 1964;187:137-140.

Spiegel PS, Kengla KW, Isaacson AS, et al. Intervertebral disc-space inflammation in children. J Bone Joint Surg Am. 1972;54:284-296.

Spivak JM, Johnson MG. Percutaneous treatment of vertebral body pathology. J Am Acad Orthop Surg. 2005;13:6-17.

Steinbach HL, Dodds WJ. Clinical radiology of Paget’s disease. Clin Orthop Relat Res. 1968;57:277-297.

Steinbach HL. The roentgen appearance of osteoporosis. Radiol Clin North Am. 1964;2:191-207.

Swenson R, Haldeman S. Spinal manipulative therapy for low back pain. J Am Acad Orthop Surg. 2003;11:228-237.

Thompson GH. Back pain in children. J Bone Joint Surg Am. 1993;75:928-938.

Toussirot E, Wendling D. Therapeutic advances in ankylosing spondylitis. Exp Opin Invest Drugs. 2001;10:21-29.

Tribus CB. Degenerative lumbar scoliosis: evaluation and management. J Am Acad Orthop Surg. 2003;11:174-183.

Tropiano P, Huang RC, Girardi FP, et al. Lumbar total disc replacement. Seven to eleven-year follow-up. J Bone Joint Surg. 2005;87:490-496.

Turner PG, Green JH, Galasko CS. Back pain in childhood. Spine. 1989;14:812-814.

Turner RH, Bianco AJJr. Spondylolysis and spondylolisthesis in children and teen-agers. J Bone Joint Surg Am. 1971;53:1298-1306.

Ugwonali OF, Lomas G, Choe JC, et al. Effect of bracing on the quality of life of adolescents with idiopathic scoliosis. Spine J. 2004;4:254-260.

Vaccaro AR, Martyak GG, Madigan L. Adult isthmic spondylolisthesis. Orthopedics. 2001;24:1172-1177.

van der Heijde D. New directions in classification and outcome assessment in ankylosing spondylitis. Curr Rheumatol Rep. 2004;6:98-101.

Vanichkachorn JS, Vaccaro AR. Thoracic disk disease: diagnosis and treatment. J Am Acad Orthop Surg. 2000;8:159-169.

Voss LA, Fadale PD, Hulstyn MJ. Exercise-induced loss of bone density in athletes. J Am Acad Orthop Surg. 1998;6:349-357.

Waldenstrom J. Diagnosis and treatment of multiple myeloma. New York: Grune & Stratton Inc, 1970.

Wolson AH, Rohwedder JJ. Upper lobe fibrosis in ankylosing spondylitis. Am J Roentgenol Radium Ther Nucl Med. 1975;124:466-471.

Wedgwood RJ, Schaller JG. The pediatric arthritides. Hosp Pract. 1977;12:95-97. 83–589–90

Weinerman SA, Bockman RS. Medical therapy of osteoporosis. Orthop Clin North Am. 1990;21:109-124.

Weinstein SL. Adolescent idiopathic scoliosis: prevalence and natural history. Instr Course Lect. 1989;38:115-128.

Wenger DR, Bobechko WP, Gilday DL. The spectrum of intervertebral disc-space infection in children. J Bone Joint Surg Am. 1978;60:100-108.

Wetzel FT, McNally TA. Treatment of chronic discogenic low back pain with intradisk electrothermal therapy. J Am Acad Orthop Surg. 2003;11:6-11.

Wheeler M. Osteoporosis. Med Clin North Am. 1976;60:1213-1224.

Williams PC. The conservative management of lesions of the lumbosacral spine. Am Acad Orthop Surg Lect. 1953;10:90.

Wiltse LL, Widell EHJr, Jackson DW. Fatigue fracture: the basic lesion is inthmic spondylolisthesis. J Bone Joint Surg Am. 1975;57:17-22.

Yoshihara K, Nakayama Y, Fujii N, et al. Atrophy of the multifidus muscle in patients with lumbar disc herniation: histochemical and electromyographic study. Orthopedics. 2003;26:493-495.

Yuan PS, Albert TJ. Nonsurgical and surgical management of lumbar spinal stenosis. J Bone Joint Surg. 2004;86A:2320.

Yukawa Y, Lenke LG, Tenhula J, et al. A comprehensive study of patients with surgically treated lumbar spinal stenosis with neurogenic claudication. J Bone Joint Surg Am. 2002;84-A:1954-1959.